Inhibitors of protein farnesylation 1998
- 1 May 1998
- journal article
- Published by Informa Healthcare in Expert Opinion on Therapeutic Patents
- Vol. 8 (5) , 553-569
- https://doi.org/10.1517/13543776.8.5.553
Abstract
Protein farnesyltransferase (PFTase) inhibitors are being studied as mechanistically novel antitumour agents. Whilst the antiproliferative effects of PFTase inhibitors are well-documented in cell culture and rodent animal models, clinical studies which began in 1997 should soon reveal their utility in human cancer patients. This review summarises the scientific and patent literature covering PFTase inhibition that has been published since the previous two updates [1,2]. New biology with a potential impact on the utility of PFTase inhibitors is reviewed first, followed by a discussion of new PFTase inhibitors. As in earlier updates, compounds are grouped according to their kinetic mechanism of PFTase inhibition.Keywords
This publication has 38 references indexed in Scilit:
- A Farnesyltransferase Inhibitor Induces Tumor Regression in Transgenic Mice Harboring Multiple Oncogenic Mutations by Mediating Alterations in Both Cell Cycle Control and ApoptosisMolecular and Cellular Biology, 1998
- Prenylation-dependent Association of Ki-Ras with MicrotubulesJournal of Biological Chemistry, 1997
- Inhibition of the prenylation of K-Ras, but not H- or N-Ras, is highly resistant to CAAX peptidomimetics and requires both a farnesyltransferase and a geranylgeranyltransferase I inhibitor in human tumor cell linesOncogene, 1997
- Farnesyltransferase inhibitors versus Ras inhibitorsCurrent Opinion in Chemical Biology, 1997
- CA1A2X-competitive inhibitors of farnesyltransferase as anti-cancer agentsTrends in Pharmacological Sciences, 1997
- Farnesyltransferase Inhibitors Alter the Prenylation and Growth-stimulating Function of RhoBJournal of Biological Chemistry, 1997
- K- and N-Ras Are Geranylgeranylated in Cells Treated with Farnesyl Protein Transferase InhibitorsJournal of Biological Chemistry, 1997
- The Ras-related Protein Rheb Is Farnesylated and Antagonizes Ras Signaling and TransformationJournal of Biological Chemistry, 1997
- Patent Update Oncologic, Endocrine & Metabolic: Oncologic, Endocrine & Metabolic: Inhibitors of protein farnesylationExpert Opinion on Therapeutic Patents, 1996
- Inhibition of farnesyltransferase induces regression of mammary and salivary carcinomas in ras transgenic miceNature Medicine, 1995